Literature DB >> 10590073

Normal neutrophil function in cathepsin G-deficient mice.

D M MacIvor1, S D Shapiro, C T Pham, A Belaaouaj, S N Abraham, T J Ley.   

Abstract

Cathepsin G is a neutral serine protease that is highly expressed at the promyelocyte stage of myeloid development. We have developed a homologous recombination strategy to create a loss-of-function mutation for murine cathepsin G. Bone marrow derived from mice homozygous for this mutation had no detectable cathepsin G protein or activity, indicating that no other protease in bone marrow cells has the same specificity. Hematopoiesis in cathepsin G-/- mice is normal, and the mice have no overt abnormalities in blood clotting. Neutrophils derived from cathepsin G-/- mice have normal morphology and azurophil granule composition; these neutrophils also display normal phagocytosis and superoxide production and have normal chemotactic responses to C5a, fMLP, and interleukin-8. Although cathepsin G has previously shown to have broad spectrum antibiotic properties, challenges of mice with Staphylococcus aureus, Klebsiella pneumoniae, or Escherichia coli yielded survivals that were not different from those of wild-type animals. In sum, cathepsin G-/- neutrophils have no obvious defects in function; either cathepsin G is not required for any of these normal neutrophil functions or related azurophil granule proteases with different specificities (ie, neutrophil elastase, proteinase 3, azurocidin, and/or others) can substitute for it in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10590073

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Endothelium-dependent relaxation induced by cathepsin G in porcine pulmonary arteries.

Authors:  E Glusa; C Adam
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 2.  Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.

Authors:  Brice Korkmaz; Marshall S Horwitz; Dieter E Jenne; Francis Gauthier
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 3.  Neutrophil-derived serine proteases in immune complex-mediated diseases.

Authors:  Sofia Z Raptis; Christine T N Pham
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 4.  Neutrophil serine proteases fine-tune the inflammatory response.

Authors:  Christine T N Pham
Journal:  Int J Biochem Cell Biol       Date:  2007-11-29       Impact factor: 5.085

5.  A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense.

Authors:  George H Caughey
Journal:  Curr Respir Med Rev       Date:  2006-08

6.  Cathepsin G-regulated release of formyl peptide receptor agonists modulate neutrophil effector functions.

Authors:  Josh C Woloszynek; Ying Hu; Christine T N Pham
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

7.  Cathepsin G activity lowers plasma LDL and reduces atherosclerosis.

Authors:  Jing Wang; Sara Sjöberg; Ting-Ting Tang; Katariina Oörni; Wenxue Wu; Conglin Liu; Blandine Secco; Viviane Tia; Galina K Sukhova; Cleverson Fernandes; Adam Lesner; Petri T Kovanen; Peter Libby; Xiang Cheng; Guo-Ping Shi
Journal:  Biochim Biophys Acta       Date:  2014-08-01

8.  Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.

Authors:  Almudena Ortega-Gomez; Melanie Salvermoser; Jan Rossaint; Robert Pick; Janine Brauner; Patricia Lemnitzer; Jessica Tilgner; Renske J de Jong; Remco T A Megens; Janina Jamasbi; Yvonne Döring; Christine T Pham; Christoph Scheiermann; Wolfgang Siess; Maik Drechsler; Christian Weber; Jochen Grommes; Alexander Zarbock; Barbara Walzog; Oliver Soehnlein
Journal:  Circulation       Date:  2016-09-22       Impact factor: 29.690

9.  Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice.

Authors:  Steve D Swain; Terry W Wright; Peter M Degel; Francis Gigliotti; Allen G Harmsen
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

10.  The chymase mouse mast cell protease 4 degrades TNF, limits inflammation, and promotes survival in a model of sepsis.

Authors:  Adrian M Piliponsky; Ching-Cheng Chen; Eon J Rios; Piper M Treuting; Asha Lahiri; Magnus Abrink; Gunnar Pejler; Mindy Tsai; Stephen J Galli
Journal:  Am J Pathol       Date:  2012-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.